Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUniversal H3N2 influenza controlled human infection model study
NL-OMON57923Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Aug 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial in influenza, sponsored by Centre for Human Drug Research. Primary endpoints: Infection rate after inoculation, Symptomatic infection rate after inoculation and 4 more. Started Aug 2025; status: completed.
02
Conditions
influenza
Beyond the preview
Go deeper on NL-OMON57923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57923.